COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive?

It has been a year since the Indonesian government announced its first COVID-19 identified in Jakarta. Since then, there have been more than 900,000 cases in Indonesia with case fatality rate (CFR) of 2.9%. The number of new cases per day is now ranging from 9,000 cases to almost 13,000 cases. Not...

Full description

Saved in:
Bibliographic Details
Main Authors: Siti Setiati, Jessica Marsigit
Format: Article
Language:English
Published: Interna Publishing 2021-03-01
Series:Acta Medica Indonesiana
Subjects:
Online Access:http://www.actamedindones.org/index.php/ijim/article/view/1766
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839630209361379328
author Siti Setiati
Jessica Marsigit
author_facet Siti Setiati
Jessica Marsigit
author_sort Siti Setiati
collection DOAJ
description It has been a year since the Indonesian government announced its first COVID-19 identified in Jakarta. Since then, there have been more than 900,000 cases in Indonesia with case fatality rate (CFR) of 2.9%. The number of new cases per day is now ranging from 9,000 cases to almost 13,000 cases. Not only in Indonesia, but the number of new cases along with the mortality rate in other countries, such as Malaysia, Japan, United States, and Europe region also increased dramatically. COVID-19 vaccines are being investigated and the world hopes that vaccines will be the answer to tackle this pandemic. Is it really so? Immunization is an effort to induce immunity in individuals to prevent a disease or the complication related to the diseases that may be catastrophic. Immunization can be divided into passive, which is by giving certain type of antibody and active, which means that either we get the disease, or we get the antigen injected into our body. Having prior vaccination or past COVID-19 does not mean that someone is totally immune to COVID-19 as a recent study suggested that the antibody related to COVID-19 past infection is significantly decreasing after 3 months post-infection. Compliance to implementation of health protocol remained the most crucial strategy during this pandemic.
format Article
id doaj-art-d92f88f2d8d24c47b9f15e689ab7fbfb
institution Matheson Library
issn 0125-9326
2338-2732
language English
publishDate 2021-03-01
publisher Interna Publishing
record_format Article
series Acta Medica Indonesiana
spelling doaj-art-d92f88f2d8d24c47b9f15e689ab7fbfb2025-07-14T07:01:41ZengInterna PublishingActa Medica Indonesiana0125-93262338-27322021-03-01531COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive?Siti Setiati0Jessica Marsigit11. Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital, Jakarta, Indonesia. 2. Clinical Epidemiology and Evidence-Based Medicine, Cipto Mangunkusumo Hospital, Jakarta, Indonesia.Department of Internal Medicine, Faculty of Medicine Universitas Indonesia-Cipto Mangunkusumo Hospital, Jakarta, Indonesia It has been a year since the Indonesian government announced its first COVID-19 identified in Jakarta. Since then, there have been more than 900,000 cases in Indonesia with case fatality rate (CFR) of 2.9%. The number of new cases per day is now ranging from 9,000 cases to almost 13,000 cases. Not only in Indonesia, but the number of new cases along with the mortality rate in other countries, such as Malaysia, Japan, United States, and Europe region also increased dramatically. COVID-19 vaccines are being investigated and the world hopes that vaccines will be the answer to tackle this pandemic. Is it really so? Immunization is an effort to induce immunity in individuals to prevent a disease or the complication related to the diseases that may be catastrophic. Immunization can be divided into passive, which is by giving certain type of antibody and active, which means that either we get the disease, or we get the antigen injected into our body. Having prior vaccination or past COVID-19 does not mean that someone is totally immune to COVID-19 as a recent study suggested that the antibody related to COVID-19 past infection is significantly decreasing after 3 months post-infection. Compliance to implementation of health protocol remained the most crucial strategy during this pandemic. http://www.actamedindones.org/index.php/ijim/article/view/1766COVID-19vaccineelderlyCOVID-19 vaccine
spellingShingle Siti Setiati
Jessica Marsigit
COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive?
Acta Medica Indonesiana
COVID-19
vaccine
elderly
COVID-19 vaccine
title COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive?
title_full COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive?
title_fullStr COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive?
title_full_unstemmed COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive?
title_short COVID-19 Vaccine for Elderly: Should We Be Reactive or Proactive?
title_sort covid 19 vaccine for elderly should we be reactive or proactive
topic COVID-19
vaccine
elderly
COVID-19 vaccine
url http://www.actamedindones.org/index.php/ijim/article/view/1766
work_keys_str_mv AT sitisetiati covid19vaccineforelderlyshouldwebereactiveorproactive
AT jessicamarsigit covid19vaccineforelderlyshouldwebereactiveorproactive